Market revenue in 2023 | USD 14.2 million |
Market revenue in 2030 | USD 23.0 million |
Growth rate | 7.1% (CAGR from 2023 to 2030) |
Largest segment | Disposable apheresis kits |
Fastest growing segment | Devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Disposable Apheresis Kits, Devices |
Key market players worldwide | Asahi Kasei Corp, Terumo Corp, Fresenius SE & Co KGaA, Haemonetics Corp, B. Braun, Nikkiso Co Ltd, Mallinckrodt PLC Ordinary Shares - New |
Disposable apheresis kits was the largest segment with a revenue share of 74.65% in 2023. Horizon Databook has segmented the Denmark apheresis equipment market based on disposable apheresis kits, devices covering the revenue growth of each sub-segment from 2018 to 2030.
The Denmark apheresis equipment market is a rapidly expanding sector, fueled by the rising demand for healthcare services & the growing incidence of orthopedic conditions. The number of medical device companies in Denmark has increased with an emphasis on advanced technology, imaging & diagnostics, medical software, and medical devices.
The Danish Medicines Agency, responsible for the registration and approval of medical devices, regulates the medical device sector in the country. Companies are focusing on developing arthroscopic suture anchors to cater to the increasing demand for minimally invasive procedures. Players are entering undertaking collaborations and acquisitions to strengthen their market presence and gain access to new technologies & distribution channels.
Healthcare providers in Denmark are increasingly emphasizing patient-specific solutions and valuebased care, which is driving demand for products that can offer better outcomes. For instance, in September 2023, the Novo Nordisk Foundation invested up to USD 136.52 million to establish the Novo Nordisk Foundation Cellerator, a facility at the Technical University of Denmark (DTU). It is focused on the development and upscaling of cell therapies for chronic diseases.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account